M
1.43
0.03 (2.14%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - General (US) | 看涨 | 看跌 |
| Drug Manufacturers - General (全球的) | 看涨 | 看跌 | |
| 股票 | MIRA Pharmaceuticals, Inc. | 混合的 | 混合的 |
AIStockmoo 评分
-0.5
| 分析师共识 | 2.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.0 |
| 平均 | -0.50 |
|
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - General |
| 内部持股比例 | 19.68% |
| 机构持股比例 | 5.60% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| First American Bank | 30 Jun 2025 | 20,000 |
| Cary Street Partners Financial Llc | 30 Jun 2025 | 10,000 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合